India’s Serum Institute Invests in IntegriMedical of Indiana
Pune-based Serum Institute of India (SII) announced a strategic investment in IntegriMedical, based in Bainbridge, IN. where SII will acquire a 20% stake in the company. This partnership aims to advance IntegriMedical’s Needle-Free Injection System (N-FIS) technology, aligning with SII’s vision of ‘Health for All’ and IntegriMedical’s mission to ‘Transform Healthcare Globally.”
N-FIS utilizes a high-velocity jet stream powered by
mechanical force to effectively and consistently administer biologics and
liquid medications without needles. This needle-free drug delivery solution
seeks to alleviate pain during administration, providing needle-phobic patients
with a more pleasant and stress-free experience while enhancing medication
efficacy through needle-free dispersion.
Comments
Post a Comment